Share
8,420 Posts.
lightbulb Created with Sketch. 257
clock Created with Sketch. 02/09/17
09:01
Share
Originally posted by musky45
↑
Yeah, they are shocking. Its just free fluff to attract users to their paid service (which is still devoid of quantitative analysis for the most part). Interesting re: the R&D Tax rebate. I was always under the impression that this related to the Vaccines business (an entirely separate entity), so i can't see why it would no longer receive an R&D rebate even though its major shareholder (Admedus Ltd) has revenues of >$20M from its other wholly owned subsidiaries. (Admedus Regen, and whatever Infusions trades as).No way . If revenue only grew 16% in the next 3 years, (unless costs were dramatically slashed again), AHZ would be out of cash much sooner than that - particularly given that they don't expect any R&D rebates.
Expand
Agree...they are rubbish.. good luck to anyone relying on them...I have written to Morgans in relation to what I consider two seriously flawed figures in the most recent review...guess what..no response..wasted space imo
